ES2150150T3 - LACTONE DERIVATIVES OF 17-BETA-CARBOXI, CARBONATE AND AMIDA ANDROSTAN DERIVATIVES. - Google Patents
LACTONE DERIVATIVES OF 17-BETA-CARBOXI, CARBONATE AND AMIDA ANDROSTAN DERIVATIVES.Info
- Publication number
- ES2150150T3 ES2150150T3 ES96942493T ES96942493T ES2150150T3 ES 2150150 T3 ES2150150 T3 ES 2150150T3 ES 96942493 T ES96942493 T ES 96942493T ES 96942493 T ES96942493 T ES 96942493T ES 2150150 T3 ES2150150 T3 ES 2150150T3
- Authority
- ES
- Spain
- Prior art keywords
- derivatives
- androstan
- carboxi
- amida
- beta
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0066—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by a carbon atom forming part of an amide group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
- C07J3/005—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom the carbon atom being part of a carboxylic function
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
- C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
LA INVENCION SE REFIERE A COMPUESTOS DE LA SERIE DEL ANDROSTANO, DE FORMULA GENERAL (I) Y A SOLVATOS DE LOS MISMOS, EN DONDE R 1 REPRESENTA O, S O NH; R 2 REPRESENTA INDIVIDUALMENTE OC(= O)ALQUILO C 1-6 ; R 3 REPRESENTA INDI VIDUALMENTE HIDROGENO, METILO (QUE PUEDE ESTAR TANTO EN CONFIGURACION AL COMO BE ) O METILENO; O R 2 Y R 3 UNID OS REPRESENTAN (A), DONDE R 6 Y R 7 SON IGUALES O DISTINTOS Y CADA UNO REPRESENTA HIDROGENO O ALQUILO C 1-6 ; R 4 Y R 5 SON IGUALES O DISTINTOS Y CADA UNO REPRESENTA HIDROGENO O HALOGENO; Y (B) REPRESENTA UN ENLACE SENCILLO O DOBLE. LOS COMPUESTOS DE FORMULA (I) Y SUS SOLVATOS SE UTILIZAN EN MEDICINA COMO AGENTES ANTIINFLAMATORIOS O ANTIALERGICOS.THE INVENTION REFERS TO COMPOUNDS OF THE ANDROSTAN SERIES, IN GENERAL FORMULA (I) AND TO SOLVATES THEREOF, WHERE R 1 REPRESENTS O, S OR NH; R 2 INDIVIDUALLY REPRESENTS OC (= O) ALKYL C 1-6; R 3 INDI REPRESENTS VIDUALLY HYDROGEN, METHYL (WHICH MAY BE BOTH IN CONFIGURATION AS COMO BE) OR METHYLENE; OR R 2 AND R 3 UNITS REPRESENT (A), WHERE R 6 AND R 7 ARE THE SAME OR DIFFERENT AND EACH REPRESENTS HYDROGEN OR ALKYL C 1-6; R 4 AND R 5 ARE THE SAME OR DIFFERENT AND EACH REPRESENTS HYDROGEN OR HALOGEN; AND (B) REPRESENTS A SINGLE OR DOUBLE LINK. FORMULA (I) COMPOUNDS AND THEIR SOLVATES ARE USED IN MEDICINE AS ANTI-INFLAMMATORY OR ANTI-ALLERGIC AGENTS.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9526651.6A GB9526651D0 (en) | 1995-12-29 | 1995-12-29 | Compounds |
GBGB9613121.4A GB9613121D0 (en) | 1996-06-21 | 1996-06-21 | Compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2150150T3 true ES2150150T3 (en) | 2000-11-16 |
Family
ID=26308402
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES96942493T Expired - Lifetime ES2150150T3 (en) | 1995-12-29 | 1996-12-19 | LACTONE DERIVATIVES OF 17-BETA-CARBOXI, CARBONATE AND AMIDA ANDROSTAN DERIVATIVES. |
Country Status (34)
Country | Link |
---|---|
US (1) | US6197761B1 (en) |
EP (1) | EP0876392B1 (en) |
JP (1) | JP2947944B2 (en) |
KR (1) | KR19990076859A (en) |
CN (1) | CN1133643C (en) |
AP (1) | AP9801274A0 (en) |
AT (1) | ATE194356T1 (en) |
AU (1) | AU721865B2 (en) |
BG (1) | BG102625A (en) |
BR (1) | BR9612309A (en) |
CA (1) | CA2241728A1 (en) |
CZ (1) | CZ207498A3 (en) |
DE (1) | DE69609199T2 (en) |
DK (1) | DK0876392T3 (en) |
EA (1) | EA001401B1 (en) |
EE (1) | EE9800227A (en) |
ES (1) | ES2150150T3 (en) |
GR (1) | GR3034564T3 (en) |
HK (1) | HK1012193A1 (en) |
HU (1) | HUP9903707A3 (en) |
IL (1) | IL124938A0 (en) |
IS (1) | IS4781A (en) |
MX (1) | MX9805181A (en) |
NO (1) | NO311022B1 (en) |
NZ (1) | NZ324373A (en) |
OA (1) | OA10701A (en) |
PE (1) | PE87598A1 (en) |
PL (1) | PL327629A1 (en) |
PT (1) | PT876392E (en) |
SI (1) | SI0876392T1 (en) |
SK (1) | SK89198A3 (en) |
TR (1) | TR199801247T2 (en) |
TW (1) | TW498072B (en) |
WO (1) | WO1997024365A1 (en) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU8439998A (en) * | 1997-06-30 | 1999-01-25 | Glaxo Group Limited | Compounds |
GB9909229D0 (en) * | 1999-04-23 | 1999-06-16 | Glaxo Group Ltd | Enantiomers of mercapto lactones and processes for their synthesis |
GB0017988D0 (en) * | 2000-07-21 | 2000-09-13 | Glaxo Group Ltd | Novel process |
US6858596B2 (en) * | 2000-08-05 | 2005-02-22 | Smithkline Beecham Corporation | Formulation containing anti-inflammatory androstane derivative |
US6759398B2 (en) * | 2000-08-05 | 2004-07-06 | Smithkline Beecham Corporation | Anti-inflammatory androstane derivative |
GB0019172D0 (en) | 2000-08-05 | 2000-09-27 | Glaxo Group Ltd | Novel compounds |
US6858593B2 (en) | 2000-08-05 | 2005-02-22 | Smithkline Beecham Corporation | Anti-inflammatory androstane derivative compositions |
US6777399B2 (en) * | 2000-08-05 | 2004-08-17 | Smithkline Beecham Corporation | Anti-inflammatory androstane derivative compositions |
US6777400B2 (en) | 2000-08-05 | 2004-08-17 | Smithkline Beecham Corporation | Anti-inflammatory androstane derivative compositions |
US6750210B2 (en) | 2000-08-05 | 2004-06-15 | Smithkline Beecham Corporation | Formulation containing novel anti-inflammatory androstane derivative |
US6787532B2 (en) | 2000-08-05 | 2004-09-07 | Smithkline Beecham Corporation | Formulation containing anti-inflammatory androstane derivatives |
DZ3468A1 (en) * | 2000-08-05 | 2002-02-14 | Glaxo Group Ltd | 6.ALPHA., 9.ALPHA.-DIFLUORO-17.ALPHA.-`(2-FURANYLCARBOXYLE) OXY! -11.BETA.-HYDROXY-16.ALPHA.-METHYLE-3-OXO-ANDROST-1,4, -DIENE-17-CARBOTHIOIC ACID S-FLUOROMETHYL ESTER USED AS ANTI-INFLAMMATORY AGENT |
UA77656C2 (en) | 2001-04-07 | 2007-01-15 | Glaxo Group Ltd | S-fluoromethyl ester of 6-alpha, 9-alpha-difluoro-17-alpha-[(2-furanylcarbonyl)oxy]-11-beta-hydroxy-16- alpha-methyl-3-oxoandrosta-1,4-dien-17-beta-carbothioacid as anti-inflammatory agent |
CN1302007C (en) * | 2001-04-30 | 2007-02-28 | 葛兰素集团有限公司 | Anti-inflammatory 17. beta-carbothioate ester derivatives of androstane with a cyclic ester group in position 17. alpha |
ATE399174T1 (en) * | 2001-06-12 | 2008-07-15 | Glaxo Group Ltd | NEW ANTI-INFLAMMATORY 17.ALPHA.-HETEROCYCLIC ESTERS OF 17.BETA.-CARBOTHIOATE ANDROSTANE DERIVATIVES |
WO2003018575A1 (en) * | 2001-08-24 | 2003-03-06 | Wyeth Holdings Corporation | 5-substituted-3(2h)-furanones useful for inhibition of farnesyl-protein transferase |
GB0125259D0 (en) * | 2001-10-20 | 2001-12-12 | Glaxo Group Ltd | Novel compounds |
WO2003042229A1 (en) * | 2001-11-12 | 2003-05-22 | Glaxo Group Limited | Non-aromatic heterocyclic esters of furan-2-one-esters of 17.beta.-carboxyl or 17.beta.-carbothio glucocorticoids |
GB0127160D0 (en) * | 2001-11-12 | 2002-01-02 | Glaxo Group Ltd | Novel compounds |
US20050175545A1 (en) * | 2002-02-04 | 2005-08-11 | Keith Biggadike | Formulation for inhalation comprising a glucocorticoid and a beta 2-adrenoreceptor agonist |
GB0202635D0 (en) * | 2002-02-05 | 2002-03-20 | Glaxo Wellcome Mfg Pte Ltd | Formulation containing novel anti-inflammatory androstane derivative |
GB2389530B (en) | 2002-06-14 | 2007-01-10 | Cipla Ltd | Pharmaceutical compositions |
EP1611149A1 (en) * | 2003-04-04 | 2006-01-04 | Alpharma APS | Process for the preparation of steroidal carbothioic acid derivatives and intermediates |
EP1466920A1 (en) * | 2003-04-04 | 2004-10-13 | Alpharma APS | Process for the preparation of steroidal 17 beta-carbothioates |
PT103202B (en) | 2004-10-19 | 2011-01-27 | Hovione Farmaciencia S A | PROCESS FOR THE ESTERIFICATION OF A CARBOOTHYTIC ACID |
GB0507165D0 (en) * | 2005-04-08 | 2005-05-18 | Glaxo Group Ltd | Novel crystalline pharmaceutical product |
TWI374147B (en) * | 2006-01-27 | 2012-10-11 | Sun Pharma Advance Res Company Ltd | Novel 11β-hydroxyandrosta-4-ene-3-ones |
GB0615108D0 (en) * | 2006-07-28 | 2006-09-06 | Glaxo Group Ltd | Novel formulations |
CN103087137A (en) * | 2011-11-07 | 2013-05-08 | 天津金耀集团有限公司 | Glucocorticoid with sulfoalkyl group at position 21 |
WO2024125639A1 (en) * | 2022-12-16 | 2024-06-20 | 津药生物科技(天津)有限公司 | Novel glucocorticoid, method for preparing same, and use thereof |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4093721A (en) * | 1974-08-30 | 1978-06-06 | Glaxo Laboratories Limited | Pharmaceutical compositions of 6α,9α-difluoro-androst-4-ene-17β-carboxylates and derivatives thereof |
US4188385A (en) * | 1978-04-05 | 1980-02-12 | Syntex (U.S.A.) Inc. | Thioetianic acid derivatives |
SE8306370D0 (en) * | 1983-11-18 | 1983-11-18 | Draco Ab | NOVEL ANDROSTANE-17BETA-CARBOXYLIC ACID ESTERS, A PROCESS AND INTERMEDIATES FOR THEIR PREPARATION, COMPOSITIONS AND METHOD FOR THE TREATMENT OF INFLAMMATORY CONDITIONS |
IL78144A0 (en) * | 1985-04-04 | 1986-07-31 | Draco Ab | Novel androstane-17beta-carboxylic acid esters |
US5767113A (en) * | 1995-05-10 | 1998-06-16 | The Salk Institute For Biological Studies | Compounds useful for concurrently activating glucocorticoid-induced response and reducing multidrug resistance |
-
1996
- 1996-12-19 SK SK891-98A patent/SK89198A3/en unknown
- 1996-12-19 BR BR9612309A patent/BR9612309A/en not_active Application Discontinuation
- 1996-12-19 US US09/091,748 patent/US6197761B1/en not_active Expired - Fee Related
- 1996-12-19 NZ NZ324373A patent/NZ324373A/en unknown
- 1996-12-19 WO PCT/GB1996/003140 patent/WO1997024365A1/en not_active Application Discontinuation
- 1996-12-19 AT AT96942493T patent/ATE194356T1/en not_active IP Right Cessation
- 1996-12-19 CN CNB961801077A patent/CN1133643C/en not_active Expired - Lifetime
- 1996-12-19 EA EA199800484A patent/EA001401B1/en not_active IP Right Cessation
- 1996-12-19 CZ CZ982074A patent/CZ207498A3/en unknown
- 1996-12-19 KR KR1019980704986A patent/KR19990076859A/en not_active Application Discontinuation
- 1996-12-19 AP APAP/P/1998/001274A patent/AP9801274A0/en unknown
- 1996-12-19 JP JP9524095A patent/JP2947944B2/en not_active Expired - Fee Related
- 1996-12-19 IL IL12493896A patent/IL124938A0/en unknown
- 1996-12-19 PL PL96327629A patent/PL327629A1/en unknown
- 1996-12-19 EP EP96942493A patent/EP0876392B1/en not_active Expired - Lifetime
- 1996-12-19 DK DK96942493T patent/DK0876392T3/en active
- 1996-12-19 HU HU9903707A patent/HUP9903707A3/en unknown
- 1996-12-19 AU AU11409/97A patent/AU721865B2/en not_active Ceased
- 1996-12-19 CA CA002241728A patent/CA2241728A1/en not_active Abandoned
- 1996-12-19 EE EE9800227A patent/EE9800227A/en unknown
- 1996-12-19 ES ES96942493T patent/ES2150150T3/en not_active Expired - Lifetime
- 1996-12-19 SI SI9630232T patent/SI0876392T1/en unknown
- 1996-12-19 PT PT96942493T patent/PT876392E/en unknown
- 1996-12-19 TR TR1998/01247T patent/TR199801247T2/en unknown
- 1996-12-19 DE DE69609199T patent/DE69609199T2/en not_active Expired - Fee Related
-
1997
- 1997-06-26 TW TW086108975A patent/TW498072B/en active
- 1997-06-27 PE PE1997000549A patent/PE87598A1/en not_active Application Discontinuation
-
1998
- 1998-06-19 OA OA9800089A patent/OA10701A/en unknown
- 1998-06-23 IS IS4781A patent/IS4781A/en unknown
- 1998-06-25 MX MX9805181A patent/MX9805181A/en unknown
- 1998-06-26 NO NO19983004A patent/NO311022B1/en not_active IP Right Cessation
- 1998-07-13 BG BG102625A patent/BG102625A/en unknown
- 1998-12-16 HK HK98113683A patent/HK1012193A1/en not_active IP Right Cessation
-
2000
- 2000-10-04 GR GR20000402254T patent/GR3034564T3/en not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2150150T3 (en) | LACTONE DERIVATIVES OF 17-BETA-CARBOXI, CARBONATE AND AMIDA ANDROSTAN DERIVATIVES. | |
AR034475A1 (en) | ANTI-INFLAMMATORY ANDROSTANE DERIVATIVES | |
ES2053778T3 (en) | PROCEDURE FOR THE OBTAINING OF TIAZOL DERIVATIVES. | |
UY24555A1 (en) | NEW COMPOUNDS | |
ES2058185T3 (en) | DERIVATIVES OF CAMPTOTECINA AND PROCEDURE FOR ITS PREPARATION. | |
ES2175741T3 (en) | NEW DERIVATIVES OF SULFINIC ACID, ITS PREPARATION PROCEDURE AND ITS USE. | |
ES2054860T3 (en) | NEW DERIVATIVES OF 9-HALOGEN- (Z) -POSTTAGLANDINAS, PROCEDURE FOR ITS PREPARATION, AS WELL AS ITS USE AS MEDICINES. | |
ES2059491T3 (en) | DERIVATIVES OF INDOL WITH CONDENSED RINGS. | |
AR032361A1 (en) | DERIVATIVES OF ANDROSTAN AND SALTS AND SOLVATOS OF THE SAME, ITS USE FOR THE MANUFACTURE OF MEDICINES, PHARMACEUTICAL COMPOSITIONS THAT INCLUDE SUCH COMPOUNDS, PROCESS FOR THE PREPARATION OF SUCH COMPOUNDS, AND USEFUL INTERMEDIARIES IN THE PREPARATION OF SUCH COMPOUNDS | |
ES2053609T3 (en) | DERIVATIVES OF UREA LIPOXIGENASA INHIBITORS. | |
ES2191183T3 (en) | 6,6- OR 6,7-BICYCLE DERIVATIVES CONTAINING REPLACED OR REQUIRED PIRIMIDO. | |
MX9300786A (en) | HYPOLIPIDAEMIC COMPOUNDS. | |
ES2040276T3 (en) | DERIVATIVES OF INDOLIZINE, PROCEDURE FOR ITS PREPARATION AND COMPOSITIONS THAT CONTAIN THEM. | |
ES2058527T3 (en) | CONDENSED DERIVATIVES OF PIRIMIDINE PROCEDURE AND INTERMEDIATE COMPOUNDS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM. | |
ES2031841T3 (en) | A PROCEDURE FOR THE PREPARATION OF DERIVATIVES OF 2-AMINOALKYL-1,2-BENZOISOTIAZOL-3- (2H) ONA 1,1-DIOXIDE. | |
ES2122018T3 (en) | 2-NITRO-P-PHENYLENDIAMINES HYDROXYPROPILATED, ITS PREPARATION PROCEDURE AND ITS USE IN THE STAINING OF KERATINIC FIBERS. | |
ES2064700T3 (en) | DERIVATIVES OF ADENOSINE WITH PHARMACEUTICAL ACTIVITY AS ANTI-HYPERTENSIVES. | |
ES2100314T3 (en) | DERIVATIVES OF PIRIMIDINE, ITS PREPARATION PROCEDURE, INTERMEDIATE PRODUCTS OBTAINED, ITS APPLICATION AS MEDICINES AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM. | |
ES2159734T3 (en) | 2-HETEROARILALQUENILIC DERIVATIVES OF THE CYCLOPENTAN-HEPTAN ACID AS THERAPEUTIC AGENTS FOR THE TREATMENT OF OCULAR HYPERTENSION. | |
ES2043665T3 (en) | 6,11-DIHIDRO-11- (4-PIPERIDILIDEN) -5H-BENZO- (5,6) -CICLOHEPTA- (1,2-B) -PIRIDINS AND COMPOSITIONS AND METHODS OF USE. | |
ES2051754T3 (en) | USE OF KETONIC DERIVATIVES IN THE TREATMENT OF DEPRESSION. | |
ES2039200T3 (en) | ISOTIAZOLONIC DERIVATIVES. | |
ES2052585T3 (en) | USE OF KETONIC DERIVATIVES IN THE TREATMENT OF COGNITIVE DISORDERS. | |
AR025796A1 (en) | QUINAZOLINONAS | |
ES2134409T3 (en) | SUPPRESSIVE FORMULATIONS AGAINST HEPATIC METASTASIS OF TUMORS. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 876392 Country of ref document: ES |